[go: up one dir, main page]

WO2002007701A2 - Lingettes humides - Google Patents

Lingettes humides Download PDF

Info

Publication number
WO2002007701A2
WO2002007701A2 PCT/US2001/023201 US0123201W WO0207701A2 WO 2002007701 A2 WO2002007701 A2 WO 2002007701A2 US 0123201 W US0123201 W US 0123201W WO 0207701 A2 WO0207701 A2 WO 0207701A2
Authority
WO
WIPO (PCT)
Prior art keywords
substrate
topical
skin
wet
nonwoven
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/023201
Other languages
English (en)
Other versions
WO2002007701A3 (fr
Inventor
David John Pung
Robert John Elsbrock
Michael Edward Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Priority to AU2001280712A priority Critical patent/AU2001280712A1/en
Publication of WO2002007701A2 publication Critical patent/WO2002007701A2/fr
Publication of WO2002007701A3 publication Critical patent/WO2002007701A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Definitions

  • the present invention relates to wet topical wipes comprising an aqueous carrier in contact with a nonwoven, fluid-entangled, flexible substrate, wherein the substrate is selected to have a defined Substrate Residue Value.
  • Topical wipes containing a flexible substrate and an aqueous carrier are well known for a variety of applications, including topical application to human skin or other applied surface to provide such surfaces with cleansing, moisturizing, depositing of actives or other materials, disinfecting, and/or any other effect that can be accomplished by application of a topical wipe to the desired surface.
  • topical wipes include baby wipes, sanitizing hand wipes, moisturizing wipes, facial cleansing wipes, and so forth.
  • topical wipes are commercially available or otherwise known in the various arts, many of which comprise a disposable flexible substrate that contains an aqueous carrier and any other desired material that is suitable for application to the skin.
  • the flexible substrates in these topical wipes are often made from disposable nonwoven or paper materials having the desired characteristics in view of the intended application.
  • a nonwoven material is often selected to provide the optimal combination of substrate characteristics such as raw material and manufacturing costs, softness during application, tensile strength, absorption capacity, and other similar characteristics.
  • a nonwoven substrate is most typically selected which exhibits the optimal combination of application softness or tensile strength as such substrate characteristics would benefit most product applications.
  • wet topical wipes can be manufactured which contain a soft, flexible, nonwoven substrate and an aqueous carrier, wherein the wet topical wipes feel soft during application to rough surfaces and leave little or no visible substrate residue during application, provided that the flexible substrate is a fluid-entangled, nonwoven, flexible substrate having a Substrate Residue Value as described hereinafter of from about 0.1 mg/cm 2 about 1.2 mg/cm 2 .
  • the Substrate Residue Value is a measure that correlates with the visible amount of substrate residue remaining on the applied surface after application.
  • the present invention relates to topical wipes for application to the skin, and methods of using the wipes on the skin.
  • the topical wipes comprise an aqueous carrier in contact with a flexible, nonwoven, fluid-entangled, substrate, wherein the substrate has a Substrate Residue Value of from about 0.1 mg/cm 2 to about 1.2 mg/cm 2 .
  • the topical wipes are applied to the skin or other surface to provide the desired topical effect such as refreshment, cleansing, moisturizing, active or other material application, and so forth.
  • the topical wipes of the present invention are especially useful for application to human skin, provided that the wipes have the selected Substrate Residue Value. It has been found that these wipes when used with an aqueous carrier provide improved softness during application and contact with the skin, and leave less substrate residue on the skin after application especially when the substrate is applied to rough skin such as human male or shaven skin.
  • FIG. 1 illustrates a cross-sectional view of a Rub Tester Weight Assembly for use in the Substrate Residue Methodology described herein.
  • the Rub Tester Weight Assembly is part of a Southerland Ink Rub Tester also for use in the Substrate Residue Methodology described herein.
  • the illustrated assembly comprises a clip (A), sandpaper (B), cardboard (C), rubber pad (D) and 2 lb. weight (E). DETAILED DESCRIPTION OF THE INVENTION
  • the topical wipes of the present invention comprise or are directed to an aqueous carrier contained within a fluid-entangled, nonwoven, flexible substrate, wherein the substrate has a selected Substrate Residue Value as defined in accordance with the methodology described herein.
  • Substrate Residue Value refers to a defined range of values obtained by the Substrate Residue Methodology as defined herein. These values represent the amount of substrate residue per area of substrate (mg/cm 2) that is measured according the defined methodology. These values are an indirect measure of and correlate to the amount of visible substrate residue, e.g., substrate fibers, left on the skin after topical application of the wet topical wipe of the present invention on skin. Lower Substrate Residue Values correlate with lower visible substrate residue on the skin after application.
  • wet topical wipe refers to the article of the present invention, and the article to which the methods of the present invention are directed, and which comprises a fluid-entangled, nonwoven, flexible substrate impregnated, coated or otherwise in contact with an aqueous carrier liquid for the purpose of rubbing the wet topical wipe over the surface of the skin to provide the skin with the desired benefit.
  • ambient conditions refers to surrounding conditions under about one (1) atmosphere of pressure, at about 50% relative humidity, and at " about 25°C, unless otherwise specified. All values, amounts and measurements described herein are obtained under ambient conditions unless otherwise specified.
  • topical wipes and corresponding methods of application of the present invention can comprise, consist of, or consist essentially of the essential elements and limitations of the invention described herein, as well as any additional or optional ingredients, components, or limitations known or otherwise effective for use in such compositions.
  • compositions of the present invention comprise a fluid-entangled, nonwoven, flexible substrate characterized by a selected Substrate Residue Value.
  • a fluid-entangled, nonwoven, flexible substrate characterized by a selected Substrate Residue Value.
  • Any fluid-entangled, nonwoven, flexible substrate that is known or is otherwise suitable for topical application to the skin can be used in the wet topical wipes of the present invention, provided that the substrate also has the requisite Substrate Residue Value.
  • the fluid-entangled, nonwoven, flexible substrates for use in the wet wipes of the present invention are generally known in the art, but it is believed that such substrates having the defined Substrate Residue Value have not previously been described in a wet wipe application, especially as such application is directed to or tailored to the application of the wet wipe to rough skin such as male facial skin or freshly shaven skin.
  • Fluid-entangled, nonwoven, flexible substrates and the fluid entangling techniques for making them are well known in the substrate arts, preferred examples of such substrates and fluid entangling techniques being described in U.S. Patents 5,142,752 (Greenway et al.) and U.S.
  • Patents 5,281,461 (Greenway et al.), which patents are incorporated herein by reference in their entirety.
  • These preferred fluid-entangled, nonwoven, flexible substrates comprise a symmetrical array of entangled staple fibers including a lattice structure of spaced parallel machine direction oriented rows of criss-crossing fibrous bands, and spaced cross-direction oriented fibrous bands, said machine direction fibrous bands and said cross-direction fibrous bands intersecting at dense fiber nodes, said symmetrical array of fibers having a ratio in the range of 1/1 to 4/1; wherein said symmetrical array of fibers is fluid entangled by discrete streams of focused fluid energy which have a confluence corresponding to said symmetrical array.
  • the machine direction fibrous bands and the criss-crossing fibrous bands further comprise connecting interstitial fiber components which substantially occupy interstitial spaces defined by said fibrous bands, such that the fabric has a non-apertured textile-like finish.
  • These substrates are preferably a blend of polyester and rayon or cotton fibers and have a weight in the range of 40-120 gsy (grams per square yard).
  • These preferred substrates are most typically prepared by using an apparatus and related process for entangling a fibrous web which employs columnar fluid jets to eject a continuous curtain of fluid in an entangling station.
  • the web is advanced through an entangling station on a conveyor which supports an entangling member having a symmetrical pattern of void areas.
  • Baffle members disposed in the void areas are provided which include radiused curvatures and define apertures having a frusto-conical configuration. Dynamic forces in the fluid curtain impact the web in discrete and controlled patterns determined by the baffling members to enhance efficient energy transfer and web entanglement.
  • Textile-like fabrics having a uniform, non-apertured, surface cover are obtained by coaction of fluid curtain and baffle structures.
  • fluid-entangled is an art recognized term which refers generally to the manufacturing process for entangling a fibrous web by using a fluid jet on a fibrous web to obtain the desired fiber and void configuration within the resulting fluid-entangled substrate, to thereby produce an art recognized, fluid-entangled, nonwoven, flexible substrate.
  • nonwoven as used herein is likewise an art recognized term which distinguishes over woven fabrics in that the nonwoven substrate contain fibers that are not woven into a fabric but rather are formed into a sheet, mat, or pad layer.
  • the fibers within the nonwoven substrate can be randomly aligned, oriented in primarily one direction, or otherwise oriented in some other nonwoven pattern depending upon the fluid entanglement manufacturing process used.
  • flexible as used herein is likewise an art recognized term which refers generally to thin, soft substrates having a substrate thickness of not more than about 2 cm, and that readily conform to the contour of the applied surface during application.
  • the nonwoven, flexible substrate for use in the present invention must have a Substrate Residue Value of from about 0.1 mg/cm 2 to about 1.2 mg/cm 2 , preferably from about 0.2 mg/cm 2 to about 1.0 mg/cm 2 , most preferably from about 0.5 mg/cm 2 about 0.8 mg/cm 2 .
  • the Substrate Residue Value is determined in accordance with methodology described hereinafter.
  • the nonwoven, flexible substrate preferably has an average size (e.g., topical area) of not more than about 650 cm 2 , preferably from about 90 cm 2 to about 550cm 2 , more preferably from about 275cm 2 to about 47590cm 2 , and can be manufactured in any suitable shape, most typically as a square, rectangular, circular or oval shape, or variation thereof. Most typical are square or rectangular shaped substrates. It has been found that most consumers briefly apply the wet topical wipes to the desired area of the skin using one hand, typically their dominant hand, and that the wet topical wipes are more efficiently used when the surface area of the nonwoven, flexible substrate correlates with or is similar to the surface area of the dominant hand that applies the topical wipe to the skin.
  • an average size e.g., topical area
  • the fluid-entangled, nonwoven, flexible substrate may be derived from or comprised of a variety of materials both natural and synthetic.
  • natural is meant that the materials are derived from plants, animals, insects or byproducts of plants, animals, and insects.
  • synthetic is meant that the materials are obtained primarily from various man-made materials or from natural materials which have been further altered.
  • the conventional base starting material is usually a fibrous web comprising any of the common synthetic or natural textile-length fibers, or mixtures thereof.
  • Nonlimiting examples of natural materials in the fluid-entangled, nonwoven, flexible substrate may include silk fibers, keratin fibers, cellulosic fibers and combinations thereof.
  • Nonlimiting examples of keratin fibers include wool fibers, camel hair fibers, and other similar materials.
  • Nonlimiting examples of cellulosic fibers include wood pulp fibers, cotton fibers, hemp fibers, jute fibers, flax fibers, and combinations thereof.
  • Nonlimiting examples of synthetic materials in the fluid-entangled, nonwoven, flexible substrate may include those acetate fibers, acrylic fibers, cellulose ester fibers, modacrylic fibers, polyamide fibers, polyester fibers, polyolefm fibers, polyvinyl alcohol fibers, rayon fibers, polyurethane foam, and combinations thereof.
  • Nonlimiting examples of synthetic materials include acrylics such as acrilan, creslan, and the acrylonitrile-based fiber (orlon); cellulose ester fibers such as cellulose acetate, arnel, and accelerator; polyamides such as nylons (e.g., nylon 6, nylon 66, nylon 610, and the like); polyesters such as fortrel, kodel, and the polyethylene terephthalate fiber, dacron; polyolefins such as polypropylene, polyethylene; polyvinyl acetate fibers; polyurethane foams and mixtures thereof.
  • acrylics such as acrilan, creslan, and the acrylonitrile-based fiber (orlon); cellulose ester fibers such as cellulose acetate, arnel, and accelerator
  • polyamides such as nylons (e.g., nylon 6, nylon 66, nylon 610, and the like)
  • polyesters such as fortrel, kodel, and the polyethylene terephthalate
  • Nonwoven substrates made from synthetic materials useful in the present invention can also be obtained from a wide variety of commercial sources.
  • suitable nonwoven layer materials useful herein include BBA Nubtex, a patterned hydroentangled material containing about 70% rayon and 30% polyester, and having a basis weight of about 57 grams per square yard (gsy), available from BBA Nonwovens, Bethune, S.C.;
  • the fluid-entangled, nonwoven, flexible substrate component described herein is preferably a patterned substrate, examples of which include mechanical embossed substrates, apertured substrates, and three-dimensional patterned substrates, the latter of which is most preferred herein.
  • Patterned substrates are well known in the various wipe and substrate arts, all of which are suitable for use herein provided that such patterned substrates also have the requisite Substrate Residue Value.
  • Mechanical embossing in the art typically involves the application of force to a web through rigid members, such as protrusions on the periphery of a roll, to create areas of high density in the substrate, without changing the basis weight of the high density areas.
  • Aperturing substrates to provide contour is likewise well known in the art and most typically involves the creation of a network of fiber bundles around a series of holes or apertures.
  • Three dimensional substrating is described in PCT Patent Publication WO 99/25318, published May 27, 1999, which description is incorporated herein by reference.
  • These three-dimensional substrates comprise a pattern having a plurality of discrete, raised fibrous regions, wherein the raised fibrous regions have a density which is substantially the same as the density of the base surface, and wherein the raised fibrous regions are joined to said base surface by a fibrous transition region.
  • the fluid-entangled, nonwoven, flexible substrate for use in the topical wipes and methods of the present invention also contains the aqueous carrier described herein, and is therefore not a dry wipe product for purposes of the present invention.
  • the aqueous carrier component of the present invention is described in greater detail hereinafter.
  • the wet disposable wipe of the present invention comprises an aqueous liquid that impregnates, coats or is otherwise in contact with the fluid-entangled, nonwoven, flexible substrate described hereinbefore.
  • the aqueous liquid can include any single or multiphase liquid that is suitable for topical application to the skin, and will typically comprise from about 50% to about 99.9%, preferably from about 70% to about 99%, by weight of water.
  • the aqueous liquid can be a solution, suspension, dispersion, emulsion or other liquid or fluid form.
  • the aqueous liquid component of the wet topical wipes is in contact with the flexible substrate component described hereinbefore.
  • the amount of aqueous liquid associated with any individual wet wipe will vary depending upon the desired characteristics of the finished wet wipe product, but should be at least an amount sufficient to result in deposition of at least some of the aqueous liquid onto the skin during application. To that desired end, the aqueous liquid will therefore most typically represent from about 50% to about 400%, preferably from about 100% to about 300%, by weight of the nonwoven, flexible substrate.
  • the aqueous carrier may be any aqueous liquid suitable for topical application to the skin.
  • the aqueous carrier comprises water and optionally one or more other organic or inorganic carrier liquids, wherein the water component represents from about 50% to about 99%, preferably from about 70% to about 98%, more preferably from about 85% to 98%, by weight of the aqueous carrier.
  • the aqueous carrier preferably further comprises one or more other carrier liquids other than water, examples of which include any volatile or nonvolatile, organic or inorganic, silicone- containing or non-silicone containing liquid compatible with the fluid-entangled, nonwoven, flexible substrate described hereinbefore and otherwise suitable for topical application to the skin.
  • the concentration of such other carrier liquids is preferably from about 0.1% to about 50%, more preferably from about 0.1% to about 30%, by weight of the aqueous carrier liquid.
  • Nonlimiting examples of such other carrier liquids suitable for use in the aqueous carrier liquid include C1-C8 monohydric alcohols, C2-C20 dihydric or polyhydric alcohol; alkyl ethers of all such alcohols; polyoxylated polyols such as propylene glycols and polyethethylene glycols having from 2 to 30 repeating alkoxylate (e.g., ethoxylate or propoxylate) groups; polyglycerols having from 2 to 16 repeating glycerol moieties; derivatives and combinations thereof.
  • Nonlimiting examples of suitable alcohol carrier liquids include propylene glycol, hexylene glycol, dipropylene glycol; tripropylene glycol; glycerin; propylene glycol methyl ether; dipropylene glycol methyl ether; ethanol, n-propanol, n-butanol, t-butanol, 2-methoxyethanol, 2- ethoxyethanol, ethylene glycol, isopropanol, isobutanol, 1,2-butylene glycol, 2,3-butylene glycol, tirmethylene glycol, 1,3-butanediol, 1,4-butanediol, propylene glycol monoisostearate, PPG-3 myristyl ether, PEG-4, PEG-8, 1,2-pentanediol, PPG-14 butylether, dimethyl isosorbide, and combinations thereof.
  • suitable carrier liquids for use in the aqueous carrier component of the wet wipe of the present invention include volatile and nonvolatile silicones such as those described in U.S. Patent U.S. Patent 5,891,424 (Bretzler et al.), which description is incorporated herein by reference.
  • volatile silicone liquids include cyclomethicones such having from 3 to 7 silicone atoms (e.g., cyclohexasiloxane, cyclopentasiloxane, cyclotetrasiloxane) and short chain linear polydimethylsiloxanes.
  • Nonlimiting examples of nonvolatile silicones include polydimethylsiloxanes and derivatives thereof.
  • the wet topical wipe of the present invention is characterized by a fluid-entangled, nonwoven, flexible substrate having a selected Substrate Residue Value as defined in accordance with the following methodology. This method is used to predict visible substrate residue that will be noted on skin, especially rough skin, after topical application of a fluid-entangled, nonwoven, flexible substrate.
  • the Substrate Residue Method can be characterized generally as a process by which a 4.3 " x 1.6" (11.0 cm x 4.0 cm) piece of the fluid-entangled, nonwoven, flexible substrate is abraded using 320 grit sandpaper and the resulting loosened fibers collected and weighed per unit area.
  • the sand paper is cut to 7.5 inch (19cm) lengths.
  • the 3M #3187 fiber removal tape is cut into 6.5 inch (16.5 cm) lengths (2 tapes for each specimen) with each end of the taped folded under approximately 0.25 inch (0.6 cm) to facilitate handling.
  • the adhesive side of the cut tape is laid onto a thick-style release paper for easier handling. All of the exposed adhesive on the cut tape is now covered by the release paper.
  • the fluid-entangled, nonwoven, flexible substrate sample is then laid out on a solid, flat surface.
  • a piece of two-sided 3M #409 tape is positioned over and attached to a substrate sample (lengthwise and aligned with the machine direction of the substrate) so that at least an 11 cm x 4 cm area of the substrate is covered by the tape in the specified alignment.
  • the taped substrate samples are cut to 11 cm (machine direction) x 4 cm (cross direction) sections making sure that all of the the resulting rectangular taped substrate sample has one side that is completely covered by the attached two sided tape.
  • the taped substrate sample is then mounted on the Sutherland Ink Rub Tester (see Figure 1) by centering and adhering (using the other side of the 2-sided adhesive tape) the taped sample onto the metal plate of the Ink Rub Tester.
  • the sandpaper (B) is then laid on top of the cardboard (C), and then both are laid on top of or positioned around the 2 lb. weight (E) component of the Ink Rub Tester, taking care to fold down the ends of the adjacent sandpaper/cardboard combination into clips (A) and making sure that the sandpaper (B) and cardboard (C) are positioned together and flat (see Figure 1) before proceeding with the following: 1.
  • the 2200 gram weight is placed onto the mounted substrate sample for 20 seconds, and then immediately lifted and removed from the sample.
  • the Ink Rub Tester is then turned on and allowed to abrade the surface of the mounted substrate for 20 rub cycles on slow speed (speed 1).
  • the substrate residue (loose fiber, fuzz) generated during the rub cycles is removed from the abraded substrate and the sandpaper and then weighed. This is accomplished by using the fiber removal tapes prepared earlier by holding the pre-weighed fiber removal tape by its folded ends, removing the release paper from the adhesive side of the tape, gently placing the adhesive-exposed part of the tape onto the sandpaper to remove all of the substrate residue, lifting the tape from the sandpaper surface and then repositioning the release paper back onto the adhesive-exposed area of the lifted tape (adhesive-exposed areas now contain subtrate residue removed from the sandpaper surface), and then weighing and recording the weight of the tape (tape + release liner + substrate residue).
  • the substrate residue generated during the rubcyles and remaining on the mounted substrate is then weighed. This is accomplished by using the pre-weighed fiber removal tapes prepared earlier by holding the pre-weighed fiber removal tape by its folded ends, removing the release paper from the adhesive side of the tape, gently placing the adhesive-exposed part of the tape onto the abraded surface of the mounted substrate, laying the 2200 gram weight on top of the non-adhesive side of the tape for 20 seconds (thus applying a defined weight the abraded substrate in contact with the adhesive side of the fiber removal tape), immediately lifting and removing the 2200 gram weight from the tape, and then lifting the tape from the surface of the mounted substrate (collecting all substrate residue and also manually removing from the abraded surface and adding to the adhesive any noticeable pilled fibers which may have stayed on the abraded surface after removal of the adhesive) and then repositioning the release paper back onto the adhesive-exposed area of the lifted tape (adhesive-exposed areas now contain substrate residue removed from the abraded substrate surface), and
  • the substrate residue from each sample is the sum of the weight-increase of the removal tapes from the sandpaper and from the surface of the abraded sample as described above.
  • the Substrate Residue Value for defining the wet topical wipes of the present invention is then calculated.
  • the starting weight for each piece of release tape is subtracted from the ending weight with attached substrate residue as described above. The difference will be the weight of substrate residue collected for each step of the method. For any given substrate sample, the weight of residue collected from the sandpaper and the weight of residue collected from the abraded substrate are added together to obtain the total residue weight of lost from the sample during testing.
  • This sum value is converted to milligrams (mg) and then converted from absolute weight loss to weight loss per unit area by dividing the total sum value weight of collected residue by the size of the abraded area (44.0 cm 2 ) for the unit of mg/cm 2 ', which is then a Substrate Residue Value, which is then evaluated and averaged over a ten (10) specimen average to provide the Substrate Residue Value for purposes of defining the wet topical wipe and corresponding methods of the present invention.
  • Fiber Removal Tape described herein is not substituted with any other tape or material. Using a tape with a different level of adhesive will greatly change the amount of residue removed from the nonwoven substrate.
  • the wet topical wipes of the present invention may further comprise one or more optional ingredients which may modify the physical, chemical, cosmetic or aesthetic characteristics of the compositions or serve as additional "active" components when deposited on the skin.
  • the compositions may also further comprise optional inert ingredients. These optional components may be associated with either the aqueous carrier component, the fluid-entangled, nonwoven, flexible substrate, or both, but will most typically be inco ⁇ orated into the aqueous carrier component.
  • Optional ingredients include any material known or otherwise suitable for use in personal care compositions, including substrate-containing personal care compositions such as wet topical wipes, provided that such optional materials are compatible with the essential materials described herein, or do not otherwise unduly impair product performance.
  • Nonlimiting examples of optional ingredients suitable for use in the wet topical wipes include pH buffering agents; perfumes; antimicrobials (antibacterial and/or antiviral) deodorants; antioxidants; vitamins; binders; biological actives; chelating agents; cosmetic astringents; film formers; bulking agents; absorbents; emollients; humectants; soothing agents; dyes and pigments; drying agents; skin active agents; preservatives; sensates; complexed and uncomplexed cyclodextrins; and other similar materials.
  • pH buffering agents perfumes; antimicrobials (antibacterial and/or antiviral) deodorants; antioxidants; vitamins; binders; biological actives; chelating agents; cosmetic astringents; film formers; bulking agents; absorbents; emollients; humectants; soothing agents; dyes and pigments; drying agents; skin active agents; preservatives; sensates; complexed and uncomplexed
  • Nonlimiting examples of optional complexed and uncomplexed cyclodextrins for use herein include alpha-cyclodextrin, gamma-cyclodextrin, gamma-cyclodextrins, derivatives thereof, and combinations thereof.
  • the concentration of optional cyclodextrins ranges from about 0.1% to about 5%, by weight of the aqueous liquid component of the wet topical wipe.
  • Nonlimiting examples of optional cyclodextrins for use herein are described in U.S. Patent 5,942,199 (Lucas et al.) and U.S. Patent 5,861,145 (Lucas et al.), which descriptions are inco ⁇ orated herein by reference.
  • Optional sensates for use herein include any sensate that is known or otherwise effective for use on the skin as a sensate material, nonlimiting examples of which include camphor, menthol, and other similar materials.
  • Optional sensates are most typically used at concentrations ranging from about 0.01% to about 5%, more preferably from about 0.05% to about 2%, even more preferably from about 0.05% to 1%, by weight of the aqueous liquid component of the wet topical wipe.
  • the sensates are preferably use in combination with an optional cyclodextrin, more preferably complexed into all or part of the cyclodextrins in the wet topical wipe.
  • the wet topical wipes may further comprise a surfactant, but is preferably substantially free of conventional anionic, nonionic, amphoteric, and/or zwitterionic surfactants.
  • substantially free means that the wet topical wipes preferably contain less than 3%, more preferably less than 1%, most preferably zero percent, of such conventional surfactants by weight of the aqueous canier.
  • the wet topical wipes are also preferably substantially free of binders, e.g., film forming polymeric materials applied to the substrate surface.
  • binders e.g., film forming polymeric materials applied to the substrate surface.
  • substantially free means that the substrate is not processed to contain any such binder material which is applied to and in contact with the substrate surface.
  • the wet topical wipes of the present invention can be made by any of a variety of techniques well known in the wet topical wipe and manufacturing arts. Once the fluid-entangled, nonwoven, flexible substrate is selected for use in the wet topical wipes, a variety of techniques can be used to coat or impregnate the substrate with the aqueous liquid component and any other optional ingredients. For example, the aqueous liquid of the present invention can be coated on the selected substrate by spraying, printing, splashing, dipping, soaking, coating, flood coating, spray coating or metered dosing the substrate with the aqueous liquid. Many other techniques or variations can be used to accomplish this combination. The substrate may be folded into stacks prior to or after adding the aqueous liquid. The wet topical wipe is then packaged in a suitable moisture and vapor impermeable package. >
  • the wet topical wipe is applied to the desired area of the skin, preferably to rough or shaven skin, more preferably to male facial skin, to release or deposit an effective amount of the aqueous liquid on the skin or to otherwise provide the desired topical effect on the area of application.
  • the method of the present invention is directed to the topical application of the wet topical wipe described herein, wherein the topical application results in little or no visible substrate residue on the areas of the skin to which the wet topical wipe was applied.
  • the methods of the present invention are especially effective in providing any one or more of benefits such as topical cleansing, skin moisturizing, topical deposition of skin active agents or other materials, topical deposition of skin deodorizing agents, skin refreshment, skin deodorizing, fragrance application, or combinations thereof.
  • the topical cleansing benefit can include the topical removal from skin of dirt, oil, cosmetics, environmental odors, body odors, or any other undesirable material that can be removed by such application.
  • the wet topical wipes of the present invention are directed to a method of refreshing the desired area of the skin.
  • the wet topical wipes of the present invention can also be applied immediately before application to the skin, e.g., within about 15 minutes of topical application.
  • the amount of aqueous liquid delivered from the wipe and frequency of topical application can vary widely, depending upon individual needs, and the topical benefit desired.
  • the wet topical wipe, especially when used to provide topical refreshment, can be applied one to several times a day, preferably one to three times per day.
  • Each of the exemplified compositions is applied topically to the skin, including rough areas of the skin such as male facial skin, forearms, neck and shaven skin, to provide refreshment of the skin.
  • Each of the exemplified compositions is also formulated with optional ingredients such as skin active agents or other materials, and then applied topically to the skin to deposit the skin active agent or other material to the desired site of application.
  • compositions are also formulated with 1) optional moisturizing agents and applied topically to the skin to provide moisturization benefits, and/or 2) a surfactant and applied topically to the skin to provide cleansing benefits.
  • each of the exemplified compositions is prepared by mixing together the listed ingredients to form an aqueous carrier, and then coating the selected fluid- entangled, nonwoven, flexible substrate with the aqueous liquid, and then packaging the resulting wet topical wipe in a moisture and vapor impervious package.
  • All exemplified amounts are weight percents based upon the total weight of the aqueous liquid component, unless otherwise specified.
  • Each exemplified composition is coated onto a 12 count stack of 68 gsm (gram/m 2 ) fluid-entangled, nonwoven, flexible substrates (70%Rayon, 30%PET) having a Substrate Residual Value of between 0.5 and 0.8.
  • Example 3 The embodiment illustrated in Example 3 is specifically prepared as follows.
  • the ammonium laurel sulfate, silicone antifoam, sodium benzoate, tetrasodium EDTA, d- gluconic acid, alcohol, fragrance and water are mixed at room temperature to form an aqueous phase.
  • the methyl isostearate, polyethylene wax, Triclosan®, dimethicone are mixed at elevated temperatures to form a water insoluble phase.
  • the water- insoluble phase is then heated to 90°C.
  • the water-insoluble mixture is allowed to cool to room temperature and is then reheated in a Hot Melt Spray unit with a 0.018" spray nozzle (KS10 Slautterback Unit).
  • the solution is brought to a temperature of 90° C and sprayed onto a moving web of the substrate in Example 1 with variable air pressure and distance from the web.
  • the coated roll is then transferred to an aqueous phase application system for loading.
  • the aqueous phase is applied onto the substrate using a lotion bar.
  • Example 4 The embodiment illustrated in Example 4 is specifically prepared as follows In a suitable vessel, the ammonium laurel sulfate, silicone antifoam, sodium benzoate, tetrasodium EDTA, d- gluconic acid, fragrance and water are mixed at room temperature to form an aqueous phase. In a separate, suitable vessel, the methyl isostearate, polyethylene wax, dimethicone are mixed at elevated temperatures to form a water insoluble phase. The water-insoluble phase is then heated to 90°C. The water-insoluble mixture is allowed to cool to room temperature and is then reheated in a Hot Melt Spray unit with a 0.018" spray nozzle (KS10 Slautterback Unit).
  • KS10 Slautterback Unit Hot Melt Spray unit with a 0.018" spray nozzle
  • the solution is brought to a temperature of 90° C and sprayed onto a moving web of the substrate in Example 1 with variable air pressure and distance from the web.
  • the coated roll is then transferred to an aqueous phase application system for loading.
  • the aqueous phase is applied onto the substrate using a lotion bar.
  • Example 5 The embodiment illustrated in Example 5 is specifically prepared as follows.
  • the ammonium laurel sulfate, silicone antifoam, sodium benzoate, tetrasodium EDTA, fragrance and water are mixed at room temperature to form an aqueous phase.
  • the methyl isostearate, polyethylene wax, dimethicone, oxybenzone, ethylhexyl p- methoxy cinnamate are mixed at elevated temperatures to form a water insoluble phase.
  • the water-insoluble phase is then heated to 90°C.
  • Example 6 Insect Repellent Wet Topical Wipe
  • Example 6 The embodiment illustrated in Example 6 is specifically prepared as follows In a suitable vessel, the ammonium laurel sulfate, silicone antifoam, sodium benzoate, tetrasodium EDTA, fragrance and water are mixed at room temperature to form an aqueous phase. In a separate, suitable vessel, the methyl isostearate, polyethylene wax, dimethicone, DEET-diethyl tolumamide are mixed at elevated temperatures to form a water insoluble phase. The water-insoluble phase is then heated to 90°C. The water-insoluble mixture is allowed to cool to room temperature and is then reheated in a Hot Melt Spray unit with a 0.018" spray nozzle (KS10 Slautterback Unit).
  • KS10 Slautterback Unit Hot Melt Spray unit with a 0.018" spray nozzle
  • the solution is brought to a temperature of 90° C and sprayed onto a moving web of the substrate in Example 1 with variable air pressure and distance from the web.
  • the coated roll is then transferred to an aqueous phase application system for loading.
  • the aqueous phase is applied onto the substrate using a lotion bar.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des lingettes topiques humides pour application cutanée ainsi que des techniques d'utilisation desdites lingettes sur des zones rugueuses de la peau, comme la peau du visage chez l'homme ou les zones soumises au rasage. Ces lingettes topiques comprennent (a) un substrat souple non tissé à enchevêtrement par fluide, dont la valeur de résidu est comprise approximativement entre 0,1 mg/cm2 et 1,2 mg/cm2, et (b) un support aqueux contenu dans le substrat souple. Ces lingettes topiques humides présentent une souplesse améliorée et permettent de réduire la quantité de résidu de substrat visible (p. ex. fibres ou peluches) restant sur la peau après application, en particulier lorsque la lingette topique est appliquée sur des zones rugueuses comme la peau du visage chez l'homme, les zones soumises au rasage ou toute autre zone similaire.
PCT/US2001/023201 2000-07-24 2001-07-23 Lingettes humides Ceased WO2002007701A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001280712A AU2001280712A1 (en) 2000-07-24 2001-07-23 Wet wipes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62432000A 2000-07-24 2000-07-24
US09/624,320 2000-07-24

Publications (2)

Publication Number Publication Date
WO2002007701A2 true WO2002007701A2 (fr) 2002-01-31
WO2002007701A3 WO2002007701A3 (fr) 2002-09-19

Family

ID=24501526

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/023201 Ceased WO2002007701A2 (fr) 2000-07-24 2001-07-23 Lingettes humides

Country Status (2)

Country Link
AU (1) AU2001280712A1 (fr)
WO (1) WO2002007701A2 (fr)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006038965A1 (fr) * 2004-09-30 2006-04-13 Kimberly-Clark Worldwide, Inc. Compositions rafraichissantes pour la peau
EP2226063A2 (fr) 2009-03-04 2010-09-08 Takasago International Corporation Fragrances de haute intensité
EP2620211A2 (fr) 2012-01-24 2013-07-31 Takasago International Corporation Nouvelles microcapsules
EP2832440A1 (fr) 2013-07-29 2015-02-04 Takasago International Corporation Microcapsules
EP2832441A1 (fr) 2013-07-29 2015-02-04 Takasago International Corporation Microcapsules
EP2832442A1 (fr) 2013-07-29 2015-02-04 Takasago International Corporation Microcapsules
US9381150B2 (en) * 2008-03-07 2016-07-05 Kimberly-Clark Worldwide, Inc. Alcohol antimicrobial skin sanitizing compositions including cationic compatible thickeners
EP3211064A1 (fr) 2016-02-24 2017-08-30 Takasago International Corporation Agent de stimulation
US9750666B2 (en) 2014-11-06 2017-09-05 Tzvi Tuvya Shwartz Wet wipe
CN109137265A (zh) * 2018-10-23 2019-01-04 厦门大学 一种三维血管电纺制造装置
EP3871765A1 (fr) 2020-02-26 2021-09-01 Takasago International Corporation Dispersion aqueuse de microcapsules et leurs utilisations
EP3871766A1 (fr) 2020-02-26 2021-09-01 Takasago International Corporation Dispersion aqueuse de microcapsules et leurs utilisations
EP3871764A1 (fr) 2020-02-26 2021-09-01 Takasago International Corporation Dispersion aqueuse de microcapsules et leurs utilisations
EP3900697A1 (fr) 2020-04-21 2021-10-27 Takasago International Corporation Composition parfumante
WO2022155054A1 (fr) 2021-01-13 2022-07-21 Firmenich Incorporated Compositions améliorant l'effet de rafraîchissement
EP4094827A1 (fr) 2021-05-27 2022-11-30 Takasago International Corporation Dispersion aqueuse de microcapsules et leurs utilisations
WO2022251628A1 (fr) 2021-05-28 2022-12-01 Firmenich Incorporated Compositions améliorant l'effet de rafraîchissement
WO2024011086A1 (fr) 2022-07-07 2024-01-11 Firmenich Incorporated Compositions améliorant l'effet de rafraîchissement
WO2024088925A1 (fr) 2022-10-27 2024-05-02 Firmenich Sa Compositions de flavonoïdes et leurs utilisations
WO2025202256A1 (fr) 2024-03-28 2025-10-02 Firmenich Sa Composition de refroidissement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141803A (en) * 1988-06-29 1992-08-25 Sterling Drug, Inc. Nonwoven wipe impregnating composition
ATE232381T1 (de) * 1997-11-19 2003-02-15 Procter & Gamble Körperreinigungswischgegenstände mit verbesserter weichheit
AU3950199A (en) * 1998-06-22 2000-01-10 Procter & Gamble Company, The Treated wipe articles
US6436885B2 (en) * 2000-01-20 2002-08-20 The Procter & Gamble Company Antimicrobial cleansing compositions containing 2-pyrrolidone-5-carboxylic acid

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006038965A1 (fr) * 2004-09-30 2006-04-13 Kimberly-Clark Worldwide, Inc. Compositions rafraichissantes pour la peau
US9381150B2 (en) * 2008-03-07 2016-07-05 Kimberly-Clark Worldwide, Inc. Alcohol antimicrobial skin sanitizing compositions including cationic compatible thickeners
EP2226063A2 (fr) 2009-03-04 2010-09-08 Takasago International Corporation Fragrances de haute intensité
EP2620211A2 (fr) 2012-01-24 2013-07-31 Takasago International Corporation Nouvelles microcapsules
WO2013111912A1 (fr) 2012-01-24 2013-08-01 Takasago International Corporation Microcapsules
EP2832440A1 (fr) 2013-07-29 2015-02-04 Takasago International Corporation Microcapsules
EP2832441A1 (fr) 2013-07-29 2015-02-04 Takasago International Corporation Microcapsules
EP2832442A1 (fr) 2013-07-29 2015-02-04 Takasago International Corporation Microcapsules
WO2015016368A1 (fr) 2013-07-29 2015-02-05 Takasago International Corporation Microcapsules
WO2015016369A1 (fr) 2013-07-29 2015-02-05 Takasago International Corporation Microcapsules
WO2015016367A1 (fr) 2013-07-29 2015-02-05 Takasago International Corporation Microcapsules
US9750666B2 (en) 2014-11-06 2017-09-05 Tzvi Tuvya Shwartz Wet wipe
WO2017146183A1 (fr) 2016-02-24 2017-08-31 Takasago International Corporation Agent stimulateur
EP3211064A1 (fr) 2016-02-24 2017-08-30 Takasago International Corporation Agent de stimulation
CN109137265A (zh) * 2018-10-23 2019-01-04 厦门大学 一种三维血管电纺制造装置
EP3871765A1 (fr) 2020-02-26 2021-09-01 Takasago International Corporation Dispersion aqueuse de microcapsules et leurs utilisations
EP3871766A1 (fr) 2020-02-26 2021-09-01 Takasago International Corporation Dispersion aqueuse de microcapsules et leurs utilisations
EP3871764A1 (fr) 2020-02-26 2021-09-01 Takasago International Corporation Dispersion aqueuse de microcapsules et leurs utilisations
EP3900697A1 (fr) 2020-04-21 2021-10-27 Takasago International Corporation Composition parfumante
WO2022155054A1 (fr) 2021-01-13 2022-07-21 Firmenich Incorporated Compositions améliorant l'effet de rafraîchissement
EP4094827A1 (fr) 2021-05-27 2022-11-30 Takasago International Corporation Dispersion aqueuse de microcapsules et leurs utilisations
WO2022249052A1 (fr) 2021-05-27 2022-12-01 Takasago International Corporation Dispersion aqueuse de microcapsules et utilisations correspondantes
WO2022251628A1 (fr) 2021-05-28 2022-12-01 Firmenich Incorporated Compositions améliorant l'effet de rafraîchissement
WO2024011086A1 (fr) 2022-07-07 2024-01-11 Firmenich Incorporated Compositions améliorant l'effet de rafraîchissement
WO2024088925A1 (fr) 2022-10-27 2024-05-02 Firmenich Sa Compositions de flavonoïdes et leurs utilisations
WO2025202256A1 (fr) 2024-03-28 2025-10-02 Firmenich Sa Composition de refroidissement

Also Published As

Publication number Publication date
AU2001280712A1 (en) 2002-02-05
WO2002007701A3 (fr) 2002-09-19

Similar Documents

Publication Publication Date Title
WO2002007701A2 (fr) Lingettes humides
AU2001262168B2 (en) Substantially dry cleansing product of improved latherability and wet flexibility
EP2046177B1 (fr) Articles nettoyants pour la peau ou les cheveux
US4206196A (en) Hair conditioning article and a method of its use
US4149551A (en) Method of conditioning hair using a flexible substrate
US4206195A (en) Hair conditioning article and a method of its use
KR20150131283A (ko) 짧은 개별 인피 섬유의 부직포 및 이로부터 제조된 제품
WO2002049604A1 (fr) Lingette humide
MXPA04012189A (es) Articulos para limpiar la piel o el cabello.
EP1628779A2 (fr) Articles nettoyants non tisses double face
WO2006005481A1 (fr) Article nettoyant pour soins d'hygiene personnelle
US8017145B2 (en) Exfoliating personal care wipe article containing an array of projections
WO2004016424A1 (fr) Article de nettoyage de surface et de soins personnels
GB2024623A (en) Hair conditioning article
US20050268442A1 (en) Mechanically extensible substrates
JP2002306367A (ja) 身体清浄用シート
MXPA06006856A (es) Pano no tejido, estampado, de peso ligero, durable.
US20050112328A1 (en) Cleaning sheet with improved three-dimensional cleaning surface
CA1146071A (fr) Revitalisant capillaire fixe sur une surface en plastique
US20050025936A1 (en) Nonwoven cleaning articles having intercalated three-dimensional images
US20040258843A1 (en) Dual sided nonwoven articles for cleaning
MXPA01000084A (en) Treated wipe articles

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ CZ DE DE DK DK DM DZ EC EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP